Loading clinical trials...
Loading clinical trials...
Interventional, Randomized, Double-blind, Sequential Cohort, Placebo-controlled, Multiple-dose Trial Investigating the Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Properties of Lu AG06474 in Healthy Young Men and Women, With an Open-label, Cross-over, Single-dose Part Investigating the Relative Bioavailability of a Capsule Formulation
Conditions
Interventions
Lu AG06474
Placebo
+1 more
Locations
1
United States
Quotient Sciences Miami
Miami, Florida, United States
Start Date
June 28, 2023
Primary Completion Date
July 19, 2024
Completion Date
July 19, 2024
Last Updated
November 18, 2024
NCT06342713
NCT07310901
NCT07401472
NCT07412353
NCT07280858
NCT07300189
Lead Sponsor
H. Lundbeck A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions